mhurhangee/ep-ind-claims huggingface dataset:
An electrode assembly, comprising a first electrode plate, a second electrode plate, and a separator disposed between the first electrode plate and the second electrode plate, and the first electrode plate and the second electrode plate being wound or stacked to form the electrode assembly; wherein the electrode assembly further comprises: a first electrode tab disposed on the first electrode plate; and an insulating layer comprising a first portion, wherein the first portion is disposed on the first electrode plate, characterized in that no part of the second electrode plate is disposed between the first portion and the first electrode tab, wherein the insulating layer is disposed between the first electrode tab and the second electrode plate. a first electrode tab disposed on the first electrode plate; and an insulating layer comprising a first portion, wherein the first portion is disposed on the first electrode plate, characterized in that no part of the second electrode plate is disposed between the first portion and the first electrode tab, wherein the insulating layer is disposed between the first electrode tab and the second electrode plate.
A bipolar trans carotenoid salt (BTCS) composition, wherein the bipolar trans carotenoid salt has the structure: YZ- TCRO-ZY where: Y = cation Z= polar group which is associated with the cation TCRO = trans carotenoid skeleton; wherein absorbency of the highest peak which occurs in the visible wave length range divided by the absorbency of the peak which occurs in the UV wave length range is greater than 7.5 for use as a medicament for the treatment of acute lung injury; or for use in the treatment of congestive heart failure; or for pretreatment or treatment during or after surgery. Y = cation Z= polar group which is associated with the cation TCRO = trans carotenoid skeleton; wherein absorbency of the highest peak which occurs in the visible wave length range divided by the absorbency of the peak which occurs in the UV wave length range is greater than 7.5 for use as a medicament for the treatment of acute lung injury; or for use in the treatment of congestive heart failure; or for pretreatment or treatment during or after surgery.
Melamine-aldehyde-condensation product obtainable by reacting at least one aldehyde, in particular formaldehyde, with a) Melamine, b) at least one melamine derivative of the general structure which is used in an amount of 1 to 45 mol% in respect to melamine, and c) at least one melamine derivative of the general structure which is used in an amount of 1 to 45 mol% in respect to melamine, wherein R 1, R 2, R 3 and R 4 mean independently from each other linear or branched C 1 -C 20 -alkyl, C 5 -C 20 -cyclo alkyl, C 5 -C 20 -aryl, C 1 -C 20 -alkylsubstituted C 5 -C 20 -aryl or cyclic amines, or wherein R 1 and R 2 or R 3 and R 4 form together an alkyl ring, wherein in each case one or multiple carbon atoms can be substituted by one or multiple oxygen atoms, sulphur atoms and/or substituted nitrogen atoms and/or by one or multiple groups of the type -C O-, -OC -, -C - and/or -OC O-, and/or can be functionalized by one or multiple hydroxyl groups and/or mercapto groups; or an amide of a carboxylic acid or an imide of a cyclic dicarboxylic acid, and wherein R 1, R 2, R 3 and R 4 can be the same or different, wherein the molar ratio of aldehyde and melamine / melamine derivatives is between 1.8: 1 and 1.3: 1. a) Melamine, b) at least one melamine derivative of the general structure which is used in an amount of 1 to 45 mol% in respect to melamine, and c) at least one melamine derivative of the general structure
A uracil compound represented by the general formula or a pharmaceutically acceptable salt thereof for use in potentiation of anti-tumor effects: wherein X represents a C 1-5 alkylene group and one of the methylene groups constituting the alkylene group is optionally replaced with an oxygen atom; R 1 represents a hydrogen atom or a C 1-6 alkyl group; R 2 represents a hydrogen atom or a halogen atom; and R 3 represents a C 1-6 alkyl group, a C 2-6 alkenyl group, a C 3-6 cycloalkyl group, a (C 3-6 cycloalkyl) C 1-6 alkyl group, a halogeno-C 1-6 alkyl group or a saturated heterocyclic group. X represents a C 1-5 alkylene group and one of the methylene groups constituting the alkylene group is optionally replaced with an oxygen atom; R 1 represents a hydrogen atom or a C 1-6 alkyl group; R 2 represents a hydrogen atom or a halogen atom; and R 3 represents a C 1-6 alkyl group, a C 2-6 alkenyl group, a C 3-6 cycloalkyl group, a (C 3-6 cycloalkyl) C 1-6 alkyl group, a halogeno-C 1-6 alkyl group or a saturated heterocyclic group.
A composition comprising bacteriophage covalently attached to a particle or pellet for use in treating bacterial infection in fish or crustaceans, wherein the particle or pellet comprises carbohydrate or protein to which bacteriophage are covalently attached.
A catalyst loading filter made of a base material of a honeycomb structure including a plurality of cells as through channels of an exhaust gas which are partitioned by partition walls made of a porous ceramic material having a large number of pores, the filter including plugging portions which alternately plug one opening end and the other opening end of each of the plurality of cells, wherein the partition walls are provided with PM collection layers having a smaller average pore diameter than that of the partition walls, characterized in that the PM collection layers include an upstream side surface, and the partition walls are coated with the catalyst without coating a portion of the PM collection layers including the upstream side surface of the PM collection layers, wherein the portion including the surface of the PM collection layers which is not coated with the catalyst is 30% or more of a thickness of PM collection layer from the surface of the PM collection layers toward the thickness direction.
A compressor stage comprising at least: a casing delimiting an air passage; a stator comprising a plurality of guide vanes arranged radially around a central axis in the air passage; and a rotor rotatable about the central axis relative to the stator and comprising a plurality of blades arranged radially around the central axis in the air passage downstream from the guide vanes, each blade of the rotor extending from a blade root to a blade tip further away from the central axis than the blade root and presenting radial clearance (j) between the blade tip and the casing; the compressor stage being characterized in that at least one of said guide vanes includes an internal cavity with a hot air inlet for deicing the guide vane, and in that the internal cavity presents a first outlet passage towards a trailing edge of the guide vane for injecting an air jet into a boundary layer adjacent to the casing upstream from the blades of the rotor. a casing delimiting an air passage; a stator comprising a plurality of guide vanes arranged radially around a central axis in the air passage; and a rotor rotatable about the central axis relative to the stator and comprising a plurality of blades arranged radially around the central axis in the air passage downstream from the guide vanes, each blade of the rotor extending from a blade root to a blade tip further away from the central axis than the blade root and presenting radial clearance (j) between the blade tip and the casing; the compressor stage being characterized in that at least one of said guide vanes includes an internal cavity with a hot air inlet for deicing the guide vane, and in that the internal cavity presents a first outlet passage towards a trailing edge of the guide vane for injecting an air jet into a boundary layer adjacent to the casing upstream from the blades of the rotor.
An electromagnetostatic electron-induced dissociation cell, comprising: a plurality of magnets (212, 214), the magnets (212, 214) having magnetic flux lines associated therewith; and an electron emitter having an electron emissive surface comprising a sheet, the emitter disposed about the axis at a location relative to the magnets (212, 214) where the electron emissive surface is substantially perpendicular to the magnetic flux lines at the electron emissive surface; wherein the plurality of magnets (212, 214) comprises a first and a second magnet each having an opening (217, 219) disposed therein, the first and second magnets disposed along a common longitudinal axis extending through the openings; wherein the emitter is disposed between the first and second magnets; and wherein the emitter comprises an opening disposed therein at a location on the axis to permit the transmission of ions along an ion beam path therethrough and the emitter is arranged to emit electrons in a region of magnetic flux where said magnetic flux lines intersect the ion beam path through the cell, and to emit said electrons in a direction along magnetic flux lines that intersect the surface of electron emission such that emitted electrons having components of velocity perpendicular to said magnetic flux lines are able to gyrate therealong to intersect the ion beam path, wherein lines of magnetic flux intersect the emitter surface in a direction substantially perpendicular thereto; and characterized in that the electron emissive surface comprises a cone shape. a plurality of magnets (212, 214), the magnets (212, 214) having magnetic flux lines associated therewith; and an electron emitter having an electron emissive surface comprising a sheet, the emitter disposed about the axis at a location relative to the magnets (212, 214) where the electron emissive surface is substantially perpendicular to the magnetic flux lines at the electron emissive surface; wherein the plurality of magnets (212, 214) comprises a first and a second magnet each having an opening (217, 219) disposed therein, the first and second magnets disposed along a common longitudinal axis extending through the openings; wherein the emitter is disposed between the first and second magnets; and wherein the emitter comprises an opening disposed therein at a location on the axis to permit the transmission of ions along an ion beam path therethrough and the emitter is arranged to emit electrons in a region of magnetic flux where said magnetic flux lines intersect the ion beam path through the cell, and to emit said electrons in a direction along magnetic flux lines that intersect the surface of electron emission such that emitted electrons having components of velocity perpendicular to said magnetic flux lines are able to gyrate therealong to intersect the ion beam path, wherein lines of magnetic flux intersect the emitter surface in a direction substantially perpendicular thereto; and characterized in that the electron emissive surface comprises a cone shape.
A network infrastructure access device in a wireless telecommunications network serving a wireless communication cell, wherein the device comprises at least one processing unit, at least one receiving unit, and at least one transmitting unit, wherein the processing unit is arranged to: • send, using the transmitting unit, an un-solicited speculative random access response, RAR, message, without knowledge of identity of connecting UE, to at least one UE in the cell comprising information relating to at least one of preamble identifier, allocated UE identifier, and uplink resource allocation data for L2/L3 message; and • receive, using the receiving unit, the L2/L3 message from the UE comprising allocated UE identifier and UE identity. • send, using the transmitting unit, an un-solicited speculative random access response, RAR, message, without knowledge of identity of connecting UE, to at least one UE in the cell comprising information relating to at least one of preamble identifier, allocated UE identifier, and uplink resource allocation data for L2/L3 message; and • receive, using the receiving unit, the L2/L3 message from the UE comprising allocated UE identifier and UE identity.
Auditory ossicle prosthesis (10; 20; 30; 40; 50; 60) which is configured for replacing or bridging at least one element of the human auditory ossicle chain, having an elongate sound-transmitting prosthesis body (13; 23; 33; 43; 53; 63) which comprises at the first end thereof a first attachment element (11; 21; 31; 41; 51; 61) which is configured for mechanical connection to the anvil projection and a receptacle part (11a; 21a; 31a; 41a; 51a; 61a) which is rigidly connected to the prosthesis body (13; 23; 33; 43; 53; 63), for receiving the free end section of the anvil projection and a U-shaped curved clip lock (11b; 21b; 31b; 41b; 51b; 61b) which is rotatably mounted in the receptacle part (11a; 21a; 31a; 41a; 51a; 61a) and for fastening the anvil projection can be pivoted over the free end section of the anvil projection which is received in the receptacle part (11a; 21a; 31a; 41a; 51a; 61a), wherein the prosthesis body (13; 23; 33; 43; 53; 63) has a second attachment element (12; 22; 32; 42; 52; 62) at the other end thereof for mechanical connection to a further member or parts of a member of the auditory ossicle chain or directly to the inner ear, characterised in that the clip lock (11b; 21b; 31b; 41b; 51b; 61b) has at least one bulge (111; 211; 311; 411; 511; 611', 611'') which is directed toward the receptacle part (11a; 21a; 31a; 41a; 51a; 61a) and projects far enough from the clip lock (11b; 21b; 31b; 41b; 51b; 61b) so that, when the clip lock (11b; 21b; 31b; 41b; 51b; 61b) is pivoted, said bulge touches an outer surface of the receptacle part (11a; 21a; 31a; 41a; 51a; 61a).
A chimeric DNA polymerase comprising the amino acid sequence of SEQ ID NO:16, containing the N-terminal domain, 3'-5' exonuclease domain and thumb domain of KOD polymerase and the palm and fingers domain of Pfu polymerase.
A method for the preparation of high-purity methiozolin (Formula 1), the method comprising reaction of 4,5-dihydro-5-methyl-3-{(3-methylthiophene-2-yl)-isoxazole-5-yl}methanol represented by Formula 2 below with 2,6-difluorobenzyl chloride (or bromide) represented by Formula 3 below in the presence of an alkali metal salt and a phase transfer catalyst in a mixed solvent system comprising water and an organic solvent at a temperature of 50 to 100°C, followed by crystallizing a concentrate of an isolated organic layer in a mixed solvent comprising water and alcohol or a mixed solvent comprising alcohol and aliphatic hydrocarbon:
A method of crimping a balloon-expandable stent in preparation for delivery into a body vessel, comprising: providing a balloon-expandable stent comprising a thin-walled tubular framework of interconnected struts, the tubular framework defining a lumen; inserting an inflatable body or a mechanically expandable apparatus into the lumen; reducing a diameter of the stent to a first compressed diameter (D 1) while applying an outward pressure to an inner surface of the tubular framework to support the stent, where applying an outward pressure comprises inflating the inflatable body or expanding the mechanically expandable apparatus to contact the inner surface of the tubular framework; halting the outward pressure after reaching the first compressed diameter; removing the inflatable body or mechanically expandable apparatus from the lumen; inserting a delivery balloon catheter into the lumen after halting the outward pressure and removing the inflatable body or mechanically expandable apparatus from the lumen, the delivery balloon catheter comprising an uninflated balloon in a delivery configuration; and reducing the diameter of the stent to a second compressed diameter (D 2) smaller than the first compressed diameter to crimp the stent onto the delivery balloon catheter. providing a balloon-expandable stent comprising a thin-walled tubular framework of interconnected struts, the tubular framework defining a lumen; inserting an inflatable body or a mechanically expandable apparatus into the lumen; reducing a diameter of the stent to a first compressed diameter (D 1) while applying an outward pressure to an inner surface of the tubular framework to support the stent, where applying an outward pressure comprises inflating the inflatable body or expanding the mechanically expandable apparatus to contact the inner surface of the tubular framework; halting the outward pressure after reaching the first compressed diameter; removing the inflatable body or mechanically expandable apparatus from the lumen; inserting a delivery balloon catheter into the lumen after halting the outward pressure and removing the inflatable body or mechanically expandable apparatus from the lumen, the delivery balloon catheter comprising an uninflated balloon in a delivery configuration; and reducing the diameter of the stent to a second compressed diameter (D 2) smaller than the first compressed diameter to crimp the stent onto the delivery balloon catheter.
A laser diode assembly comprising: a mode-locked laser diode device; an external resonator comprising a diffraction grating that directly returns primary or higher order diffracted light to the mode-locked laser diode device, and outputs 0-order diffracted light outside; a turning unit turning the diffraction grating, wherein wavelength of laser light to be returned to the mode-locked laser diode device is controlled by turning of the diffraction grating caused by operation of the turning unit; a reflecting mirror reflecting the 0-order diffracted light outputted from the diffraction grating; a correction mechanism correcting a shift of a light path of the 0-order diffracted light reflected by the reflecting mirror resulting from the turning of the diffraction grating caused by the operation of the turning unit; an imaging section provided between the mode-locked laser diode device and the diffraction grating and imaging an image of a light output end face of the mode-locked laser diode device on the diffraction grating, wherein light output from the mode-locked laser diode device passes through the imaging section before being diffracted by the diffraction grating. a mode-locked laser diode device; an external resonator comprising a diffraction grating that directly returns primary or higher order diffracted light to the mode-locked laser diode device, and outputs 0-order diffracted light outside; a turning unit turning the diffraction grating, wherein wavelength of laser light to be returned to the mode-locked laser diode device is controlled by turning of the diffraction grating caused by operation of the turning unit; a reflecting mirror reflecting the 0-order diffracted light outputted from the diffraction grating; a correction mechanism correcting a shift of a light path of the 0-order diffracted light reflected by the reflecting mirror resulting from the turning of the diffraction grating caused by the operation of the turning unit; an imaging section provided between the mode-locked laser diode device and the diffraction grating and imaging an image of a light output end face of the mode-locked laser diode device on the diffraction grating, wherein light output from the mode-locked laser diode device passes through the imaging section before being diffracted by the diffraction grating.
Improved butt joint of identical or different core materials in sandwich structures, characterized in that one or more reinforcement elements is/are introduced in the direction of thickness within a region adjacent to the butt joint to be improved within the core materials (2, 3).
An engine comprising: a combustion chamber in a cylinder; a fuel supply device configured to supply fuel containing gasoline into the combustion chamber; a control device having knock occurrence prediction means configured to predict occurrence of a knock; and a fluid injection device configured to inject a fluid into the combustion chamber, wherein the fluid injection device is configured to inject the fluid into the combustion chamber within a period before a burned mass fraction reaches about 50% after a start of combustion, when the knock occurrence prediction means predicts occurrence of a knock with a predetermined intensity or higher, the fuel supply device includes an injector configured to inject the fuel into the combustion chamber, the fluid injection device is the injector, the fluid is the fuel additionally injected, and mass of the fuel additionally injected is set to about 10% or less of total mass of the fuel injected in a combustion cycle in which the fuel is additionally injected, characterized in that injection pressure of the fluid is about 30 MPa or higher. a combustion chamber in a cylinder; a fuel supply device configured to supply fuel containing gasoline into the combustion chamber; a control device having knock occurrence prediction means configured to predict occurrence of a knock; and a fluid injection device configured to inject a fluid into the combustion chamber, wherein the fluid injection device is configured to inject the fluid into the combustion chamber within a period before a burned mass fraction reaches about 50% after a start of combustion, when the knock occurrence prediction means predicts occurrence of a knock with a predetermined intensity or higher, the fuel supply device includes an injector configured to inject the fuel into the combustion chamber, the fluid injection device is the injector, the fluid is the fuel additionally injected, and mass of the fuel additionally injected is set to about 10% or less of total mass of the fuel injected in a combustion cycle in which the fuel is additionally injected, characterized in that injection pressure of the fluid is about 30 MPa or higher.
A method of preparing a high-coercivity sintered NdFeB magnet including the steps of: Providing a NdFeB powder as a main material; Vacuum coating a layer of a rare earth alloy R x H( 100-x) on a surface of a metal nanopowder M to obtain an auxiliary alloy material with a core-shell structure, with R is at least one selected from the group of Dy, Tb, Pr, Nd, La, and Ce; H is at least one selected from the group of Cu, Al, and Ga; M is at least one selected from the group of Mo, W, Zr, Ti, and Nb; and x is 30 wt.% ≤ x ≤ 90 wt.%; and Adding the auxiliary alloy material obtained by step to the NdFeB powder of step and mixing, and after the mixture is uniformly mixed, orientation pressing of the mixture to obtain a compact body; and Sintering and annealing treatment of the compact body to obtain the high-coercivity sintered NdFeB magnet. Providing a NdFeB powder as a main material; Vacuum coating a layer of a rare earth alloy R x H( 100-x) on a surface of a metal nanopowder M to obtain an auxiliary alloy material with a core-shell structure, with R is at least one selected from the group of Dy, Tb, Pr, Nd, La, and Ce; H is at least one selected from the group of Cu, Al, and Ga; M is at least one selected from the group of Mo, W, Zr, Ti, and Nb; and x is 30 wt.% ≤ x ≤ 90 wt.%; and R is at least one selected from the group of Dy, Tb, Pr, Nd, La, and Ce; H is at least one selected from the group of Cu, Al, and Ga; M is at least one selected from the group of Mo, W, Zr, Ti, and Nb; and x is 30 wt.% ≤ x ≤ 90 wt.%; and Adding the auxiliary alloy material obtained by step to the NdFeB powder of step and mixing, and after the mixture is uniformly mixed, orientation pressing of the mixture to obtain a compact body; and Sintering and annealing treatment of the compact body to obtain the high-coercivity sintered NdFeB magnet.